The transaction is part of the Gpi Group’s plan for growth in the software for the digital transformation of healthcare sector, and is fully in line with the guidelines of the 2022-2024 Strategic Industrial Plan, aimed at consolidating Gpi as a key player in the digital health sector at European level.
The Evolucare Group, which has been operating for more than 35 years, is a leading player in software solutions for the digital transformation of French healthcare with more than 2,700 customers; in 2022, it recorded consolidated revenues of EUR 42.9 million and adjusted consolidated EBITDA of EUR 15.7 million (EBITDA margin of 37%).
The agreed price for the acquisition of approximately 96.58% of the Evolucare Group is around EUR 109 million based on an Equity Value for 100% of the fully diluted share capital of EUR 116 million, corresponding to an EV/Adj. EBITDA 2022 multiple of approximately 11.0x
